These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26379838)

  • 1. Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study.
    Song H; Wu C; Wei C; Li D; Hua K; Song J; Xu H; Chen L; Fang L
    Int J Clin Exp Med; 2015; 8(7):10481-90. PubMed ID: 26379838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated silencing of CDK8 inhibits proliferation and growth in breast cancer cells.
    Li XY; Luo QF; Wei CK; Li DF; Fang L
    Int J Clin Exp Pathol; 2014; 7(1):92-100. PubMed ID: 24427329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
    Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
    Li Z; Li D; Li J; Huang P; Qin H
    Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-155 promotes the proliferation and migration of breast cancer cells via targeting SOCS1 and MMP16.
    Zhang W; Chen CJ; Guo GL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7323-7332. PubMed ID: 30468477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis.
    Gao G; Liang X; Ma W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3839-3846. PubMed ID: 31556312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.
    Xing Z; Zhang M; Wang X; Liu J; Liu G; Feng K; Wang X
    J Mol Histol; 2021 Aug; 52(4):809-821. PubMed ID: 34009515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.
    Zhang B; Shetti D; Fan C; Wei K
    Biol Res; 2019 Jul; 52(1):38. PubMed ID: 31349873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
    Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
    Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
    Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis.
    Xu M; Lin J; Yang S; Yao J; Chen M; Feng J; Zhang L; Zhou L; Zhang J; Qin Q
    J Virol; 2023 Sep; 97(9):e0088123. PubMed ID: 37681959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
    Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro.
    Li BX; Zhang MC; Luo CL; Yang P; Li H; Xu HM; Xu HF; Shen YW; Xue AM; Zhao ZQ
    J Exp Clin Cancer Res; 2011 Oct; 30(1):90. PubMed ID: 21962223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Fibulin-2 expression with proliferation, migration and invasion of breast cancer cells.
    Zhang X; Duan L; Zhang Y; Zhao H; Yang X; Zhang C
    Oncol Lett; 2020 Aug; 20(2):1945-1951. PubMed ID: 32724439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.
    Li Y; Hua K; Jin J; Fang L
    Oncol Lett; 2021 Aug; 22(2):580. PubMed ID: 34122631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.
    Li XY; Luo QF; Wei CK; Li DF; Li J; Fang L
    Int J Clin Exp Med; 2014; 7(1):32-40. PubMed ID: 24482686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.